This blog was written by guest blogger and 2018 Promega Social Media Intern Logan Godfrey.
Only 30 years ago, the polymerase chain reaction (PCR)
was used for the first time, allowing the exponential amplification of a specific
DNA segment. A small amount of DNA could now be replicated until there was
enough of it to study accurately, even allowing sequencing of the amplified DNA.
This was a massive breakthrough that produced immediate effects in the fields
of forensics and life science research. Since these technologies were first
introduced however, the molecular biology research laboratory has been the sole
domain of PCR and DNA sequencing.
While an amazing revolution, application of a technology
such as DNA sequencing is limited by the size and cost of DNA sequencers, which
in turn restricts accessibility. However, recent breakthroughs are allowing DNA
sequencing to take place in jungles, the arctic, and even space—giving science
the opportunity to reach further, faster than ever before.
The newfound accessibility of DNA sequencing means a
marriage between fields of science that were previously largely unacquainted.
The disciplines of genomics and wildlife biology/ecology have largely progressed
independently. Wildlife biology is practiced in the field through observations
and macro-level assessments, and genomics, largely, has developed in a lab
setting. Leading the charge in the convergence of wildlife biology and genomics
is Field Projects International.
There have been many changes in sequencing technology over the course of my scientific career. In one of the research labs I rotated in as a graduate student, I assisted a third-year grad student with a manual radioactive sequencing gel because, I was told, “every student should run at least one in their career”. My first job after graduate school was as a research assistant in a lab that sequenced bacterial genomes. While I was the one creating shotgun libraries for the DNA sequencing pipeline, the sequencing reaction was performed using dideoxynucleotides labeled with fluorescent dyes and amplified in thermal cyclers. The resulting fragments were separated by manual loading on tall slab polyacrylamide gels (Applied Biosystems ABI 377s) or, once the lab got them running, capillary electrophoresis of four 96-well plates at a time (ABI 3700s).
Sequencing throughput has only increased since I left the lab. This was accomplished by increasing well density in a plate and number of capillaries for use in capillary electrophoresis, but more importantly, with the advent of the short read, massively parallel next-generation sequencing method. The next-gen or NGS technique decreased the time needed to sequence because many sequences were determined at the same time, significantly accelerating sequencing capacity. Instruments have also decreased in size as well as the price per base pair, a measurement used when I was in the lab. The long-prophesized threshold of $1,000 per genome has arrived. And now, according to a recent tweet from a Nanopore conference, you can add a sequencing module to your mobile device:
Welcome to the future – DNA sequencing on your mobile phone – imagine where and how you can use it. Hats off to the @nanopore team for getting this to work at this form factor, voltage and watts. https://t.co/Tm6A5fj8M4
As a global life sciences company, Promega participates in scientific conferences and trade shows around the world, all year long. ISHI, ASHG, SLAS, ISBER, PAG, SOT, ESHG—the alphabet of conference names may be hard to keep straight, yet preparation for each involves a strong collaboration between Promega R&D scientists, product managers and the marketing services team. A new conference on the calendar caught our attention recently, as it’s billed as a “Festival.” That’s right, the name Festival of Genomics hints at its unique nature, and true to its title, it offers a novel approach in its organization, focus and objectives.
Created and organized by a London-based media company, Front Line Genomics, the Festival is described as a “three day celebration of genomics across the spectrum from the lab to the clinic, taking in new research, technology and advances in medicine.” The young event is intended to provide an environment for scientists to gather, connect and share with their peers. The hope is that new ideas will flourish and ultimately lead to more progress in the field of genomics research.
Also somewhat novel, a different “flavor” of festival is offered in three different cities worldwide. The Boston Festival will be held June 27-29, the California (San Diego) Festival September 19-21, and the London Festival January 30–February 1, 2017. By offering it three times a year in various locations, more members of the genomics community have the opportunity to participate. And the festivals are open not only to research scientists, but to anyone who considers themselves part of that community, including academia, industry, healthcare organizations, patient organizations, and investment firms. Continue reading “Festival of Genomics: Not Your Typical Scientific Conference”
When Aristotle compared epigenetics to a net (1), he could not have predicted how right he was. Recent research has revealed that mechanisms underlying epigenetic effects are numerous and interdependent as are the knots in a net. Each epigenetic mechanism has its players: enzymes, functional groups, substrates etc. The most important aspect of an epigenetic trait is its reversibility. Methylation of DNA was the first epigenetic modification to be discovered, and 5-cytosine methylation was the first to be linked with gene expression status. Currently, the most popular method for measuring CpG island methylation status is a bisulfite treatment of DNA followed by PCR or sequencing.
When the first draft sequence of the human genome was announced, I was a research assistant for a lab that was part of the Genome Center of Wisconsin where I created shotgun libraries of bacterial genomes for sequencing. Of course, the local news organizations were all abuzz with the news and sought opinions on what this meant for the future, including that of the lab’s PI and oddly enough, my own. While I do not recall the exact words I offered on camera, I believe they were something along the lines of this is only the first step toward the future of human genetics. Ten years later, we have not fulfilled the potential of the grandiose words used to report the first draft sequence but have gained enough knowledge of what our genome holds to only intrigue scientists even more.